Australia
As of 05/19/2025, Cochlear Limited's market capitalization has reached $11.44 B. According to our data, Cochlear Limited is the 1668th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.
| Market Cap | 11.44 B |
| Revenue (ttm) | 1.49 B |
| Net Income (ttm) | 239.02 M |
| Shares Out | 65.40 M |
| EPS (ttm) | 3.64 |
| Forward PE | 40.39 |
| Ex-Dividend Date | 03/20/2025 |
| Earnings Date | 08/15/2025 |
| Date | Market Cap | Change (%) |
|---|---|---|
| 05/19/2025 | A$17.73 B | -8.35% |
| 12/31/2024 | A$18.97 B | -3.04% |
| 12/29/2023 | A$19.56 B | 45.68% |
| 12/30/2022 | A$13.43 B | -5.54% |
| 12/31/2021 | A$14.22 B | 14.41% |
| 12/31/2020 | A$12.43 B |
Cochlear Limited is a global leader in implantable hearing solutions, dedicated to improving the lives of both children and adults with hearing loss.
Founded in 1981, Cochlear Limited is headquartered in Sydney, Australia, and has since expanded its reach to serve patients worldwide.
| Country or region | Australia |
| Founded | 1981 |
| IPO Date | n/a |
| Employees | 5,097 |
| CEO | Diggory Howitt |
| Sector | Healthcare |
| Industry | Medical Devices |
| Address |
1 University Avenue Sydney, NSW 2109 Australia |
| Website | https://www.cochlear.com |
